protien kinase c inhibitors (Temple University)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameprotien kinase c inhibitors (Temple University)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionProtein kinase C delta inhibitors
TargetsProtein kinase C delta
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryRespiratory Tract Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTemple University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTemple University
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjuryRespiratory Tract Diseases

Other Information

ATC CodeN/A
Related LinksN/A